Intraperitoneal Chemotherapy for Ovarian Cancer: Where Are We Now?

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.4, Iss.9, 2006-10, pp. : 941-946

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Counterpoint: Intraperitoneal Chemotherapy: An Investigational Treatment in Ovarian Cancer

By Ozols Robert F.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 6, 2004-11 ,pp. : 555-560

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Point: Intraperitoneal Chemotherapy in the Management of Ovarian Cancer

By Markman Maurie

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 6, 2004-11 ,pp. : 549-554

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Principle and evolving role of intraperitoneal chemotherapy in ovarian cancer

By Fujiwara Keiichi

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 13, 2013-09 ,pp. : 1797-1806

Informa Healthcare

Access to resources Recommend Favorite

High-Dose Chemotherapy and Stem Cell Support for Breast Cancer: Where Are We Now?

By Gerrero R.M. Stein S. Stadtmauer E.A.

Drugs & Aging, Vol. 19, Iss. 7, 2002-01 ,pp. : 475-485

Adis International

Access to resources Recommend Favorite

Intraperitoneal Chemotherapy as First-Line Treatment in the Management of Epithelial Ovarian Cancer

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-05 ,pp. : 511-519

Bentham Science Publishers

Access to resources Recommend Favorite